Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

Go back to Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®
Pfizer Inc. (NYSE: PFE) Delayed: 27.79 --0 (-0%)
Previous Close $27.79    52 Week High $37.39 
Open $27.79    52 Week Low $28.25 
Day High $27.79    P/E 16.84 
Day Low $27.79    EPS $1.65 
Volume 34,115